Abstract
Clinical Pharmacology Update| October 14 2022 A New Medical Probiotic Formulation for the Nutritional Management of Type 2 Diabetes Jennifer D. Goldman 0000-0002-9617-3998 ; Jennifer D. Goldman 1Massachusetts College of Pharmacy and Health Sciences, Boston, MA2Well Life Medical, Peabody, MA Corresponding author: Jennifer D. Goldman, jennifer.goldman@mcphs.edu Search for other works by this author on: This Site PubMed Google Scholar Lana Dvorkin Camiel Lana Dvorkin Camiel 1Massachusetts College of Pharmacy and Health Sciences, Boston, MA Search for other works by this author on: This Site PubMed Google Scholar Corresponding author: Jennifer D. Goldman, jennifer.goldman@mcphs.edu Clin Diabetes 2022;40(4):500–502 https://doi.org/10.2337/cd22-0070 PubMed: 36385968 Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn MailTo Cite Icon Cite Get Permissions Citation Jennifer D. Goldman, Lana Dvorkin Camiel; A New Medical Probiotic Formulation for the Nutritional Management of Type 2 Diabetes. Clin Diabetes 14 October 2022; 40 (4): 500–502. https://doi.org/10.2337/cd22-0070 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsClinical Diabetes Search Advanced Search According to the Centers for Disease Control and Prevention (CDC), the prevalence of obesity among U.S. adults was 42.4% in 2017–2018 (1). The World Health Organization reports that >1 billion people worldwide have obesity. Complications associated with obesity include, but are not limited to, cardiovascular disease, diabetes, cancer, musculoskeletal disorders, and poorer outcomes from coronavirus disease 2019 (2). Type 2 diabetes rates go hand in hand with rates of obesity. The CDC estimates that 130 million U.S. adults are living with diabetes or prediabetes (3). The International Diabetes Federation estimates that 537 million adults worldwide have diabetes, and this number is predicted to increase to 643 million by 2030 and 783 million by 2045 (4). For people with type 2 diabetes, the American Diabetes Association (ADA) supports, in addition to lifestyle change, the use of pharmacological agents that minimize weight gain or... You do not currently have access to this content.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Clinical diabetes : a publication of the American Diabetes Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
